Literature DB >> 25101912

Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events.

Linnea M Baudhuin1, Katrina E Kotzer1, Susan A Lagerstedt1.   

Abstract

PURPOSE: Marfan syndrome is a systemic disorder that typically involves FBN1 mutations and cardiovascular manifestations. We investigated FBN1 genotype-phenotype correlations with aortic events (aortic dissection and prophylactic aortic surgery) in patients with Marfan syndrome.
METHODS: Genotype and phenotype information from probands (n = 179) with an FBN1 pathogenic or likely pathogenic variant were assessed.
RESULTS: A higher frequency of truncating or splicing FBN1 variants was observed in Ghent criteria-positive patients with an aortic event (n = 34) as compared with all other probands (n = 145) without a reported aortic event (79 vs. 39%; P < 0.0001), as well as Ghent criteria-positive probands (n = 54) without an aortic event (79 vs. 48%; P = 0.0039). Most probands with an early aortic event had a truncating or splicing variant (100% (n = 12) and 95% (n = 21) of patients younger than 30 and 40 years old, respectively). Aortic events occurred at a younger median age in patients with truncating/splicing variants (29 years) as compared with those with missense variants (51 years). A trend toward a higher frequency of truncating/splicing variants in patients with aortic dissection (n = 21) versus prophylactic surgery (n = 13) (85.7 vs. 69.3%; not significant) was observed.
CONCLUSION: These aortic event- and age-associated findings may have important implications for the management of Marfan syndrome patients with FBN1 truncating and splicing variants.Genet Med 17 3, 177-187.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25101912     DOI: 10.1038/gim.2014.91

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  40 in total

1.  Exon 47 skipping of fibrillin-1 leads preferentially to cardiovascular defects in patients with thoracic aortic aneurysms and dissections.

Authors:  Wen-Jing Wang; Peili Han; Jun Zheng; Fang-Yuan Hu; Yun Zhu; Jin-Sheng Xie; Jian Guo; Zhe Zhang; Jie Dong; Gu-Yan Zheng; Huiqing Cao; Tian-Shu Liu; Qinglin Fu; Lizhong Sun; Bi-Bo Yang; Xiao-Li Tian
Journal:  J Mol Med (Berl)       Date:  2012-07-08       Impact factor: 4.599

2.  Two novel fibrillin-1 mutations resulting in premature termination codons but in different mutant transcript levels and clinical phenotypes.

Authors:  L Karttunen; T Ukkonen; K Kainulainen; A C Syvänen; L Peltonen
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

3.  Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in Marfan syndrome and related conditions.

Authors:  J Körkkö; I Kaitila; L Lönnqvist; L Peltonen; L Ala-Kokko
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

4.  Evaluating Japanese patients with the Marfan syndrome using high-throughput microarray-based mutational analysis of fibrillin-1 gene.

Authors:  Naomi Ogawa; Yasushi Imai; Yuji Takahashi; Kan Nawata; Kazuo Hara; Hiroshi Nishimura; Masayoshi Kato; Norifumi Takeda; Takahide Kohro; Hiroyuki Morita; Tsuyoshi Taketani; Tetsuro Morota; Tsutomu Yamazaki; Jun Goto; Shoji Tsuji; Shinichi Takamoto; Ryozo Nagai; Yasunobu Hirata
Journal:  Am J Cardiol       Date:  2011-09-10       Impact factor: 2.778

5.  The clinical spectrum of complete FBN1 allele deletions.

Authors:  Yvonne Hilhorst-Hofstee; Ben C J Hamel; Joke B G M Verheij; Marry E B Rijlaarsdam; Grazia M S Mancini; Jan M Cobben; Cindy Giroth; Claudia A L Ruivenkamp; Kerstin B M Hansson; Janneke Timmermans; Henriette A Moll; Martijn H Breuning; Gerard Pals
Journal:  Eur J Hum Genet       Date:  2010-11-10       Impact factor: 4.246

6.  Angiotensin II Receptor Antagonism Reduces Transforming Growth Factor Beta and Smad Signaling in Thoracic Aortic Aneurysm.

Authors:  Maria Nataatmadja; Jennifer West; Sulistiana Prabowo; Malcolm West
Journal:  Ochsner J       Date:  2013

7.  Mutation spectrum of the fibrillin-1 (FBN1) gene in Taiwanese patients with Marfan syndrome.

Authors:  Chia-Cheng Hung; Shin-Yu Lin; Chien-Nan Lee; Hui-Yu Cheng; Shuan-Pei Lin; Ming-Ren Chen; Chih-Ping Chen; Chien-Hui Chang; Chiou-Ya Lin; Chih-Chieh Yu; Hsin-Hui Chiu; Wen-Fang Cheng; Hong-Nerng Ho; Dau-Ming Niu; Yi-Ning Su
Journal:  Ann Hum Genet       Date:  2009-11       Impact factor: 1.670

8.  Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome.

Authors:  H C Dietz; I McIntosh; L Y Sakai; G M Corson; S C Chalberg; R E Pyeritz; C A Francomano
Journal:  Genomics       Date:  1993-08       Impact factor: 5.736

9.  Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype?

Authors:  Sarah Hutchinson; Andre Furger; Dorothy Halliday; Daniel P Judge; Andrew Jefferson; Harry C Dietz; Helen Firth; Penny A Handford
Journal:  Hum Mol Genet       Date:  2003-07-22       Impact factor: 6.150

10.  Identification of a novel FBN1 mutation in a Chinese family with isolated ectopia lentis.

Authors:  Chen Liang; Wei Fan; Sisi Wu; Yi Liu
Journal:  Mol Vis       Date:  2011-12-29       Impact factor: 2.367

View more
  26 in total

1.  Identification of FBN1 gene mutations in Ukrainian Marfan syndrome patients.

Authors:  Rustam Zhurayev; Dorien Proost; Dmytro Zerbino; Viktor Fedorenko; Josephina A N Meester; Lut VAN Laer; Bart L Loeys
Journal:  Genet Res (Camb)       Date:  2016-10-11       Impact factor: 1.588

Review 2.  FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders.

Authors:  Lynn Y Sakai; Douglas R Keene; Marjolijn Renard; Julie De Backer
Journal:  Gene       Date:  2016-07-18       Impact factor: 3.688

Review 3.  Precision Cardiovascular Medicine: State of Genetic Testing.

Authors:  John R Giudicessi; Iftikhar J Kullo; Michael J Ackerman
Journal:  Mayo Clin Proc       Date:  2017-04       Impact factor: 7.616

4.  Decreased frequency of FBN1 missense variants in Ghent criteria-positive Marfan syndrome and characterization of novel FBN1 variants.

Authors:  Linnea M Baudhuin; Katrina E Kotzer; Susan A Lagerstedt
Journal:  J Hum Genet       Date:  2015-02-05       Impact factor: 3.172

5.  Association of modifiers and other genetic factors explain Marfan syndrome clinical variability.

Authors:  Melodie Aubart; Steven Gazal; Pauline Arnaud; Louise Benarroch; Marie-Sylvie Gross; Julien Buratti; Anne Boland; Vincent Meyer; Habib Zouali; Nadine Hanna; Olivier Milleron; Chantal Stheneur; Thomas Bourgeron; Isabelle Desguerre; Marie-Paule Jacob; Laurent Gouya; Emmanuelle Génin; Jean-François Deleuze; Guillaume Jondeau; Catherine Boileau
Journal:  Eur J Hum Genet       Date:  2018-08-07       Impact factor: 4.246

Review 6.  Precision Medicine Approaches to Vascular Disease: JACC Focus Seminar 2/5.

Authors:  Clint L Miller; Amy R Kontorovich; Ke Hao; Lijiang Ma; Conrad Iyegbe; Johan L M Björkegren; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2021-05-25       Impact factor: 24.094

Review 7.  Potential predictors of severe cardiovascular involvement in Marfan syndrome: the emphasized role of genotype-phenotype correlations in improving risk stratification-a literature review.

Authors:  Zoltán Szabolcs; Kálmán Benke; Roland Stengl; Bence Ágg; Miklós Pólos; Gábor Mátyás; Gábor Szabó; Béla Merkely; Tamás Radovits
Journal:  Orphanet J Rare Dis       Date:  2021-05-31       Impact factor: 4.123

8.  The importance of genotype-phenotype correlation in the clinical management of Marfan syndrome.

Authors:  Víctor Manuel Becerra-Muñoz; Juan José Gómez-Doblas; Carlos Porras-Martín; Miguel Such-Martínez; María Generosa Crespo-Leiro; Roberto Barriales-Villa; Eduardo de Teresa-Galván; Manuel Jiménez-Navarro; Fernando Cabrera-Bueno
Journal:  Orphanet J Rare Dis       Date:  2018-01-22       Impact factor: 4.123

Review 9.  Pathogenic Mechanisms of Bicuspid Aortic Valve Aortopathy.

Authors:  Noor M Yassine; Jasmine T Shahram; Simon C Body
Journal:  Front Physiol       Date:  2017-09-25       Impact factor: 4.566

Review 10.  The Molecular Genetics of Marfan Syndrome.

Authors:  Qiu Du; Dingding Zhang; Yue Zhuang; Qiongrong Xia; Taishen Wen; Haiping Jia
Journal:  Int J Med Sci       Date:  2021-05-27       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.